TUMOUR NECROSIS FACTOR α (TNF-α) INTERFERES WITH Fas-MEDIATED APOPTOTIC CELL DEATH ON RHEUMATOID ARTHRITIS (RA) SYNOVIAL CELLS: A POSSIBLE MECHANISM OF RHEUMATOID SYNOVIAL HYPERPLASIA AND A CLINICAL BENEFIT OF ANTI-TNF-α THERAPY FOR RA
- 31 March 2000
- Vol. 12 (3) , 281-288
- https://doi.org/10.1006/cyto.1999.0552
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Modulation by proinflammatory cytokines of Fas/Fas ligand-mediated apoptotic cell death of synovial cells in patients with rheumatoid arthritis (RA)Clinical and Experimental Immunology, 1998
- Apoptosis in rheumatoid arthritis synovium.Journal of Clinical Investigation, 1995
- Apoptosis and functional fas antigen in rheumatoid arthritis synoviocytesArthritis & Rheumatism, 1995
- Fas and Fas ligand: lpr and gld mutationsImmunology Today, 1995
- Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritisThe Lancet, 1994
- Repeated therapy with monoclonal antibody to tumour necrosis factor α (cA2) in patients with rheumatoid arthritisThe Lancet, 1994
- Generalized lymphoproliferative disease in mice, caused by a point mutation in the fas ligandCell, 1994
- Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor αArthritis & Rheumatism, 1993
- Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritisArthritis & Rheumatism, 1990
- Detection of tumor necrosis factor α but not tumor necrosis factor β in rheumatoid arthritis synovial fluid and serumArthritis & Rheumatism, 1988